In this episode of the EPRC Podcast, Sam Tullman (MPH, BCN), Head of Clinical Research at Quilt Technologies, tells host Dr. Shoshannah Bryn Jones Square about his research, including a Phase I clinical trial of n,n–DMT in Brazil for the treatment of depression. Sam is an EPRC member and a researcher and consultant in the study of Emergent practices, with primary focuses in EEG and behavior change. He received a degree in Neuroscience from the University of Pennsylvania and an MPH in Social and Behavioral Sciences from the University of Washington, and he was awarded a Fulbright Scholarship to study the neurophysiological and behavioral impacts of psychedelic substances indigenous to Brazil. His research in emergence also includes a pilot study looking at the impact of neurofeedback on interoceptive awareness and the study of the neurological mechanics of people recognizing things they know–like their sense of self. Sam has spent the last few years of his professional life consulting in the Brain-Computer Interface (BCI) space, architecting the EEG training strategy for FIELD Neuroscience Solutions, and aiding in developing “mental state” classifiers and training strategies for Atai Life Sciences’ Psyber Health. He now works at Quilt Technologies as the Head of Clinical Research, helping build machine learning models that predict mental health using phone data. His overarching interest is allowing transformative practices and experiences to be more accessible to the general population, which brings together his work in Health Communications, Psychedelic Neuroscience, and BCI. He is also a dedicated student of Rinzai Zen but draws heavily in his practice from other Buddhist traditions and from modern Western psychology & Neuroscience.   Thank you very much to Alexandre Bergeron for editing this video!